샘플 요청 목록

 카트 문의
시장보고서
상품코드
1651989

세포배양 시장 : 시장 규모, 점유율, 동향, 업계 분석(제품별, 용도별, 최종 용도별, 지역별), 예측(2025-2034년)

Cell Culture Market Share, Size, Trends, Industry Analysis Report: By Product (Consumables and Instruments), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 128 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면, 세계 세포배양 시장 규모는 2034년까지 589억 8,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.

세포배양은 약물 검사, 질병 진단, 연구 등 다양한 용도를 위해 통제된 환경에서 세포를 증식시키기 위해 사용되는 실험 기술입니다. 시장은 심혈관질환, 자가면역질환 등 만성질환의 유병률 증가를 배경으로 단클론항체 등의 분야에서의 연구개발 증가로 인해 시장이 확대되고 있습니다. 또한, 특수한 세포배양 배지에 의존하는 암, 신경질환 등의 증상에 대한 유전자 치료의 사용으로 세포배양 기술의 수요가 확대되고 있습니다. 세포배양 배지에 나노 섬유의 통합과 같은 발전은 세포배양 시장의 성장을 더욱 촉진하고 있습니다. 소규모 바이오 제약기업들의 일회용 처리법 채택도 저비용으로 효율적인 생산 방법을 제공하여 시장 확대에 기여하고 있습니다.

3D 세포배양 모델의 채택 증가는 세포배양 시장의 트렌드로, 3D 모델은 기존 2D 모델보다 생체 내 환경을 더 정확하게 재현할 수 있기 때문입니다. 이러한 모델은 세포의 성장, 분화, 자극에 대한 반응이 개선되어 신약 개발, 독성 테스트, 암 연구에 이상적입니다. 또한, 연구자들은 보다 신뢰할 수 있고 생리학적으로 적합한 데이터를 얻기 위해 3D 배양으로 전환하고 있으며, 3D 모델은 환자 맞춤형 치료법이 개발되는 맞춤형 의료에 필수적인 것으로 입증되고 있습니다. 이러한 변화는 3D 세포배양 능력을 향상시키는 스캐폴딩 및 바이오프린팅과 같은 기술의 발전으로 뒷받침되고 있습니다.

세포배양 시장 : 분석 개요

2024년 세포배양 시장에서는 바이오제약 기업, 학술연구기관, CRO에서의 사용이 주도하고 있으며, 제품별로는 소모품 부문이 큰 비중을 차지했습니다.

용도별로는 대사체학에서 세포배양의 활용이 증가하고, 다양한 질병과 관련된 바이오마커를 식별하는 데 활용되면서 진단 분야가 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

북미는 2024년 세포배양 시장을 주도했으며, 예측 기간 동안에도 그 우위를 유지할 것으로 예상됩니다. 고령화 사회의 만성질환 유병률 증가, 바이오의약품 센터의 기술 발전, 의료 연구개발에 대한 정부 지원책 및 정책 등이 그 요인으로 작용하고 있습니다.

아시아태평양의 세포배양 시장은 의료비 증가, 세포 및 유전자 치료에 대한 인식 증가, 임상연구의 방대한 기회를 배경으로 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다.

세계 주요 기업으로는 Sartorius AG, Danaher, Merck KGaA, Thermo Fisher Scientific, Inc., Corning Inc., Avantor, Inc., BD, Eppendorf SE, Bio-Techne, PromoCell GmbH 등이 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 분석 방법

제4장 세포배양 시장 인사이트

  • 시장 현황
  • 세포배양 시장 역학
    • 성장 촉진요인과 기회
      • 유전자 치료 이용 확대
      • 세포배양 시장의 진보
    • 성장 억제요인과 과제
      • 신흥 시장의 첨단 스킬을 보유한 전문가의 부족
  • PESTLE 분석
  • 세포배양 시장 동향 : 용도별
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 세포배양 시장 : 제품별

  • 주요 조사 결과
  • 소개
  • 소모품
  • 장비

제6장 세계의 세포배양 시장 : 용도별

  • 주요 조사 결과
  • 소개
  • 바이오의약품 제조
  • 의약품 개발
  • 진단
  • 조직배양·엔지니어링
  • 세포 및 유전자 치료
  • 독성 시험
  • 기타 용도

제7장 세계의 세포배양 시장 : 최종 용도별

  • 주요 조사 결과
  • 소개
  • 제약·바이오테크놀러지 기업
  • 병원·진단 검사실
  • 연구·학술기관
  • 기타

제8장 세계의 세포배양 시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 세포배양 시장 평가 : 지역별(2020-2034년)
  • 북미
    • 북미 : 제품별(2020-2034년)
    • 북미 : 용도별(2020-2034년)
    • 북미 : 최종 용도별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 제품별(2020-2034년)
    • 유럽 : 용도별(2020-2034년)
    • 유럽 : 최종 용도별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 제품별(2020-2034년)
    • 아시아태평양 : 용도별(2020-2034년)
    • 아시아태평양 : 최종 용도별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 제품별(2020-2034년)
    • 중동 및 아프리카 : 용도별(2020-2034년)
    • 중동 및 아프리카 : 최종 용도별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 남아프리카공화국
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 제품별(2020-2034년)
    • 라틴아메리카 : 용도별(2020-2034년)
    • 라틴아메리카 : 최종 용도별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 사업 확대·기업 인수 분석
    • 사업 확대
    • 기업 인수
  • 제휴/협업/합의/공개

제10장 기업 개요

  • Adolf Kuhner
  • Avantor, Inc
  • BD
  • Bio-Techne
  • Danaher
  • Merck KGaA
  • PromoCell GmbH
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Eppendorf AG
ksm 25.03.10

The global cell culture market size is expected to reach USD 58.98 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Culture Market Share, Size, Trends, Industry Analysis Report: By Product (Consumables and Instruments), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cell culture is a laboratory technique used to grow cells in a controlled environment for various applications, including drug testing, disease diagnosis, and research. The market is expanding due to increased R&D in areas such as monoclonal antibodies, driven by the rising prevalence of chronic illnesses such as cardiovascular diseases and autoimmune disorders. Additionally, the demand for cell culture techniques is growing with the use of gene therapies for conditions such as cancer and neurological disorders, which rely on specialized cell culture media. Advancements such as the integration of nanofibers into cell culture media are further boosting cell culture market growth. The adoption of single-use processing methods by small-scale biopharmaceutical companies is also contributing to the market expansion, offering low-cost, efficient production methods.

The increased adoption of 3D cell culture models is a cell culture market trend, as 3D models can reproduce the in vivo environment more accurately than traditional 2D models. These models offer improved cell growth, differentiation, and response to stimuli, making them ideal for drug discovery, toxicity testing, and cancer research. Additionally, researchers are shifting toward 3D cultures to obtain more reliable and physiologically relevant data, and 3D models are proving essential in personalized medicine, where patient-specific therapies are being developed. This shift is supported by advancements in technologies such as scaffolding and bio printing, which enhance the capabilities of 3D cell cultures.

Cell Culture Market Report Highlights

The consumables segment, by product, held a larger share of the cell culture market in 2024, driven by its use in biopharmaceutical companies, academic research, and contract research institutes.

The diagnostics segment, by application, is expected to experience the highest growth rate during the forecast period owing to the increasing use of cell cultures in metabolomics for identifying biomarkers associated with various pathologically significant conditions.

North America led the cell culture market in 2024 and is expected to maintain its dominance during the forecast period, fueled by the rising prevalence of chronic diseases in the aging population, technological advancements in biopharmaceutical centers, and supportive government initiatives and policies for medical research development.

The Asia Pacific cell culture market is anticipated to experience the fastest growth at a robust CAGR during the forecast period, driven by rising healthcare expenditure, increased awareness of cell and gene therapies, and vast opportunities for clinical research.

A few key global market players include Sartorius AG; Danaher; Merck KGaA; Thermo Fisher Scientific, Inc.; Corning Inc.; Avantor, Inc.; BD; Eppendorf SE; Bio-Techne; and PromoCell GmbH.

Polaris Market Research has segmented the cell culture market report on the basis of product, application, end use, and region.

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • Consumables
  • Sera
  • Fetal Bovine Serum
  • Other
  • Reagents
  • Albumin
  • Others
  • Media
  • Serum-Free Media
  • CHO Media
  • HEK 293 Media
  • BHK Medium
  • Vero Medium
  • Other Serum-Free Media
  • Classical Media
  • Stem Cell Culture Media
  • Chemically Defined Media
  • Specialty Media
  • Other Cell Culture Media
  • Instruments
  • Culture Systems
  • Incubators
  • Centrifuges
  • Cryostorage Equipment
  • Biosafety Equipment
  • Pipetting Instruments

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Biopharmaceutical Production
  • Monoclonal Antibodies
  • Vaccines Production
  • Other Therapeutic Proteins
  • Drug Development
  • Diagnostics
  • Tissue Culture & Engineering
  • Cell & Gene Therapy
  • Toxicity Testing
  • Other Applications

By End Use Outlook (Revenue - USD Billion, 2020-2034)

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell Culture Market Insights

  • 4.1. Cell Culture Market - Market Snapshot
  • 4.2. Cell Culture Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Expanding Use of Gene Therapies
      • 4.2.1.2. Advancements in cell culture market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The lack of highly skilled professionals in emerging markets
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell Culture Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cell Culture Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell Culture Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Consumable
    • 5.3.1. Global Cell Culture Market, by Consumable, by Region, 2020-2034 (USD Billion)
    • 5.3.2. Sera
      • 5.3.2.1. Global Cell Culture Market, by sera, by Region, 2020-2034 (USD Billion)
      • 5.3.2.2. Fetal Bovine Serum
      • 5.3.2.2.1. Global Cell Culture Market, by Fetal Bovine Serum, by Region, 2020-2034 (USD Billion)
      • 5.3.2.3. Other
      • 5.3.2.3.1. Global Cell Culture Market, by Other, by Region, 2020-2034 (USD Billion)
    • 5.3.3. Reagents
      • 5.3.3.1. Global Cell Culture Market, by Reagnts, by Region, 2020-2034 (USD Billion)
      • 5.3.3.2. Albumin
      • 5.3.3.2.1. Global Cell Culture Market, by Albumin, by Region, 2020-2034 (USD Billion)
      • 5.3.3.3. Others
      • 5.3.3.3.1. Global Cell Culture Market, by Others, by Region, 2020-2034 (USD Billion)
    • 5.3.4. Media
      • 5.3.4.1. Global Cell Culture Market, by media, by Region, 2020-2034 (USD Billion)
      • 5.3.4.2. Serum Free Media
      • 5.3.4.2.1. Global Cell Culture Market, by Serum Free Media, by Region, 2020-2034 (USD Billion)
      • 5.3.4.2.2. CHO Media
      • 5.3.4.2.2.1. Global Cell Culture Market, by CHO Media, by Region, 2020-2034 (USD Billion)
      • 5.3.4.2.3. HEK 293 Media
      • 5.3.4.2.3.1. Global Cell Culture Market, by HEK 293 Media, by Region, 2020-2034 (USD Billion)
      • 5.3.4.2.4. BHK Medium
      • 5.3.4.2.4.1. Global Cell Culture Market, by BHK Medium, by Region, 2020-2034 (USD Billion)
      • 5.3.4.2.5. Vero Medium
      • 5.3.4.2.5.1. Global Cell Culture Market, by Vero Medium, by Region, 2020-2034 (USD Billion)
      • 5.3.4.2.6. Other Serum-free Media
      • 5.3.4.2.6.1. Global Cell Culture Market, by Other Serum-free Media, by Region, 2020-2034 (USD Billion)
    • 5.3.5. Classical Media
      • 5.3.5.1. Global Cell Culture Market, by Classical Media, by Region, 2020-2034 (USD Billion)
    • 5.3.6. Stem Cell Culture Media
      • 5.3.6.1. Global Cell Culture Market, by Stem Cell Culture Media, by Region, 2020-2034 (USD Billion)
    • 5.3.7. Chemically Defined Media
      • 5.3.7.1. Global Cell Culture Market, by Chemically Defined Media, by Region, 2020-2034 (USD Billion)
    • 5.3.8. Speciality Media
      • 5.3.8.1. Global Cell Culture Market, by Speciality Media, by Region, 2020-2034 (USD Billion)
    • 5.3.9. Other Cell Cultured Media
      • 5.3.9.1. Global Cell Culture Market, by Other Cell Cultured Media, by Region, 2020-2034 (USD Billion)
  • 5.4. Instruments
    • 5.4.1. Global Cell Culture Market, by Instruments, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Culture Systems
      • 5.4.2.1. Global Cell Culture Market, by Culture Systems, by Region, 2020-2034 (USD Billion)
    • 5.4.3. Incubators
      • 5.4.3.1. Global Cell Culture Market, by Incubators, by Region, 2020-2034 (USD Billion)
    • 5.4.4. Centrifuges
      • 5.4.4.1. Global Cell Culture Market, by Centrifuges, by Region, 2020-2034 (USD Billion)
    • 5.4.5. Cryostorage Equipment
      • 5.4.5.1. Global Cell Culture Market, by Cryostorage Equipment, by Region, 2020-2034 (USD Billion)
    • 5.4.6. Biosafety Equipments
      • 5.4.6.1. Global Cell Culture Market, by Biosafety Equipments, by Region, 2020-2034 (USD Billion)
    • 5.4.7. Pipetting Instruments
      • 5.4.7.1. Global Cell Culture Market, by Pipetting Instruments, by Region, 2020-2034 (USD Billion)

6. Global Cell Culture Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell Culture Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Biopharmaceutical production
    • 6.3.1. Global Cell Culture Market, by Region, by Biopharmaceutical Production, 2020-2034 (USD Billion)
    • 6.3.2. Monoclonal Antibodies
      • 6.3.2.1. Global Cell Culture Market, by Tissue Culture & Regenerative Monoclonal Antibodies, by Region, 2020-2034 (USD Billion)
    • 6.3.3. Vaccines Production
      • 6.3.3.1. Global Cell Culture Market, by Vaccines Production, by Region, 2020-2034 (USD Billion)
    • 6.3.4. Others Therapeutic Proteins
      • 6.3.4.1. Global Cell Culture Market, by Others Therapeutic Proteins by Region, 2020-2034 (USD Billion)
  • 6.4. Drug Development
    • 6.4.1. Global Cell Culture Market, by Drug Development, by Region, 2020-2034 (USD Billion)
  • 6.5. Diagnostic
    • 6.5.1. Global Cell Culture Market, by Diagnostic, by Region, 2020-2034 (USD Billion)
  • 6.6. Tissue Culture & Engineering
    • 6.6.1. Global Cell Culture Market, by, Tissue Culture & Engineering, by Region, 2020-2034 (USD Billion)
  • 6.7. Cell & Gene Therapy
    • 6.7.1. Global Cell Culture Market, by, Cell & Gene Therapy, by Region, 2020-2034 (USD Billion)
  • 6.8. Toxicity Testing
    • 6.8.1. Global Cell Culture Market, by, Toxicity Testing, by Region, 2020-2034 (USD Billion)
  • 6.9. Other Applications
    • 6.9.1. Global Cell Culture Market, by, Other Applications by Region, 2020-2034 (USD Billion)

7. Global Cell Culture Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cell Culture Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Global Cell Culture Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
  • 7.4. Hospitals & Diagnostic Laboratories
    • 7.4.1. Global Cell Culture Market, by Hospitals & Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)
  • 7.5. Research & Academic Institutes
    • 7.5.1. Global Cell Culture Market, by Research & Academic Institutes, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Cell Culture Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Cell Culture Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Cell Culture Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Cell Culture Market - North America
    • 8.3.1. North America: Cell Culture Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Cell Culture Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Cell Culture Market - US
      • 8.3.4.1. US: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Cell Culture Market - Canada
      • 8.3.5.1. Canada: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Cell Culture Market - Europe
    • 8.4.1. Europe: Cell Culture Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Cell Culture Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Cell Culture Market - UK
      • 8.4.4.1. UK: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Cell Culture Market - France
      • 8.4.5.1. France: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Cell Culture Market - Germany
      • 8.4.6.1. Germany: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Cell Culture Market - Italy
      • 8.4.7.1. Italy: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Cell Culture Market - Spain
      • 8.4.8.1. Spain: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Cell Culture Market - Netherlands
      • 8.4.9.1. Netherlands: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Cell Culture Market - Russia
      • 8.4.10.1. Russia: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Cell Culture Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Cell Culture Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cell Culture Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Cell Culture Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Cell Culture Market - China
      • 8.5.4.1. China: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Cell Culture Market - India
      • 8.5.5.1. India: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Cell Culture Market - Malaysia
      • 8.5.6.1. Malaysia: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Cell Culture Market - Japan
      • 8.5.7.1. Japan: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Cell Culture Market - Indonesia
      • 8.5.8.1. Indonesia: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Cell Culture Market - South Korea
      • 8.5.9.1. South Korea: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Cell Culture Market - Australia
      • 8.5.10.1. Australia: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Cell Culture Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Cell Culture Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cell Culture Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Cell Culture Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Cell Culture Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Cell Culture Market - UAE
      • 8.6.5.1. UAE: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Cell Culture Market - Israel
      • 8.6.6.1. Israel: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Cell Culture Market - South Africa
      • 8.6.7.1. South Africa: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Cell Culture Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Cell Culture Market - Latin America
    • 8.7.1. Latin America: Cell Culture Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Cell Culture Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Cell Culture Market - Mexico
      • 8.7.4.1. Mexico: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Cell Culture Market - Brazil
      • 8.7.5.1. Brazil: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Cell Culture Market - Argentina
      • 8.7.6.1. Argentina: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Cell Culture Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Cell Culture Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Cell Culture Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Cell Culture Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Cell Culture Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Adolf Kuhner
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Avantor, Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BD
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Techne
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Danaher
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merck KGaA
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. PromoCell GmbH
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sartorius AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Thermo Fisher Scientific, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Eppendorf AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제